Regulatory Nebilet PMS

CompletedOBSERVATIONAL
Enrollment

743

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions
HypertensionHeart Failure
Interventions
DRUG

Nebivolol

patients administrated Nebivolol according to the prescribing information

Trial Locations (1)

130-702

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01077661 - Regulatory Nebilet PMS | Biotech Hunter | Biotech Hunter